RENB (Enochian BioSciences) Cumulative Company Assets

Official company branding of Renovaro Inc. (RENB)

Renovaro Inc. (RENB) develops cloud-based AI tools for tumor detection, providing laboratories with rapid access to biomarker analysis via API. The business viability relies on the integration of neural networks into oncology diagnostics and software monetization. This chart of total asset values shows they are at 147.90. However, the company's success depends on therapy test results, and high R&D costs necessitate strict management due to low revenue.

Renovaro Inc. (RENB) Aggregate Company Assets: for the period 02/21/2024 - 10/01/2025

Financial and market metric breakdowns for renovarobio.com (RENB)

- share price and consensus valuation forecast:
Price Chart Renovaro|RENB - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation RENB|RENB - Enterprise Value
- company book value details:
Book Value per Share Renovaro|RENB - Company Book Value|Capitalization to Book Value Ratio renovarobio.com|RENB - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Renovaro Inc.|RENB - Long-Term Debt to Capital|Current Liabilities to Capital Renovaro|RENB - Company Debts|Debt to Net Assets Ratio RENB|RENB - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Renovaro|Quick Liquidity Indicator renovarobio.com
- earnings and market multiples details:
RENB - Net Income
Basic company analysis:Enochian BioSciences (RENB)
Core merchandise of Renovaro Inc.

Total assets, reverse-calculated via ROA, reflect the aggregate volume of resources and liabilities, allowing investors to assess the actual scale of the company's fundamentals independent of market volatility. An analysis of the asset history of Renovaro Inc. (RENB) confirms the stability of its base: timely equipment calibration and the reservation of production capacities for oncology drugs ensure qualitative growth of the material base without operational downtime.

Key competitors

ONC (beigene.com) - Aggregate Company Assets|HALO (Halozyme) - Company Total Assets|Cumulative Company Assets Revolution Medicines Inc (RVMD)|Company Total Assets AAPG|Company Total Assets CG Oncology Therapeutics (CGON)|Aggregate Company Assets UroGen Pharma Ltd. URGN|BCAX: Total Business Assets|Personalis - Company Total Assets|Erasca Inc (ERAS) - Cumulative Company Assets|DCTH: Company Total Assets|Company Assets Y-mAbs Corp (YMAB)|Aggregate Company Assets Aura Biosciences, Inc.|CADL: Aggregate Asset Value|Cumulative Company Assets ARAY (Accuray)|SLS (sellaslifesciences.com) - Aggregate Asset Value|Company Total Assets ACTU (Actuate Therapeutics, Inc)|CTOR - Cumulative Company Assets|HURA: Cumulative Company Assets|TARA - Company Total Assets|Fate Therapeutics (FATE) - Aggregate Company Assets|Aadi Bioscience - Aggregate Asset Value|TCRX (TScan Therapeutics Inc) - Company Total Assets|Company Assets Champions Oncology Corp CSBR|Aggregate Company Assets XBiotech Inc. (XBIT)|CVM (cel-sci.com) - Aggregate Asset Value|Company Total Assets OSTX (OS Therapies)|radiopharmtheranostics.com (RADX) - Company Assets|ARTV - Aggregate Company Assets|ANL (Adlai Nortye Ltd.) - Total Business Assets|Veru Inc. (VERU) - Aggregate Company Assets|Company Assets tempesttx.com (TPST)|Cumulative Company Assets XLO|Aggregate Company Assets MURA|Company Total Assets KAPA|Company Total Assets onkuretherapeutics.com (OKUR)|Aggregate Company Assets CytoMed Therapeutics Limited GDTC|Aggregate Asset Value CRIS|APLM - Aggregate Company Assets|Company Assets Tharimmune Inc|ADVB (advanbiomed.com) - Cumulative Company Assets|Genprex Inc - Aggregate Asset Value|CLDI (Calidi Biotherapeutics Inc.) - Company Total Assets|sunshinebiopharma.com (SBFM) - Company Total Asset Base|Aggregate Company Assets Xenetic Biosciences (XBIO)|Salarius Pharmaceuticals Inc - Total Business Assets|Company Total Assets PPBT (Purple Biotech Corp)|AONC - Cumulative Company Assets|BGNE: Cumulative Company Assets|Company Total Asset Base checkpointtx.com CKPT|Elevation Oncology (ELEV) - Aggregate Company Assets|iCAD - Aggregate Asset Value|IKNA (Ikena Oncology Inc.) - Company Total Assets|Company Assets Notable Labs Corp NTBL|Aggregate Company Assets Viracta Therapeutics (VIRX)|morphosys.com - Total Business Assets|Company Total Assets NAYA (NAYA Biosciences Inc.)|Ascentage Pharma Group International - Aggregate Company Assets